OrthoPediatrics Corp. (NASDAQ:KIDS – Get Free Report) was the recipient of a large drop in short interest in the month of May. As of May 31st, there was short interest totalling 1,100,000 shares, a drop of 5.2% from the May 15th total of 1,160,000 shares. Currently, 6.8% of the shares of the stock are sold short. Based on an average trading volume of 151,700 shares, the days-to-cover ratio is presently 7.3 days.
Wall Street Analysts Forecast Growth
Several equities research analysts have issued reports on KIDS shares. Needham & Company LLC lifted their target price on shares of OrthoPediatrics from $37.00 to $42.00 and gave the stock a “buy” rating in a research note on Tuesday, May 7th. JMP Securities reissued a “market outperform” rating and set a $50.00 price target on shares of OrthoPediatrics in a research report on Tuesday, May 7th. Finally, Truist Financial boosted their price target on shares of OrthoPediatrics from $35.00 to $38.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th.
Institutional Trading of OrthoPediatrics
OrthoPediatrics Trading Up 0.4 %
Shares of KIDS stock opened at $29.42 on Tuesday. OrthoPediatrics has a twelve month low of $23.10 and a twelve month high of $46.58. The company’s 50-day moving average price is $31.39 and its 200-day moving average price is $29.80. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.45 and a quick ratio of 1.99.
OrthoPediatrics (NASDAQ:KIDS – Get Free Report) last issued its quarterly earnings results on Monday, May 6th. The company reported ($0.30) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.42) by $0.12. The company had revenue of $44.69 million for the quarter, compared to analyst estimates of $41.63 million. OrthoPediatrics had a negative net margin of 13.58% and a negative return on equity of 5.12%. As a group, equities analysts expect that OrthoPediatrics will post -1.2 earnings per share for the current year.
OrthoPediatrics Company Profile
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Recommended Stories
- Five stocks we like better than OrthoPediatrics
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Buffett Bails on BYD: What It Means for the Future of EV Stocks
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Domino’s vs. Papa John’s: Stock Showdown of Pizza Giants
- What is a Bond Market Holiday? How to Invest and Trade
- Williams-Sonoma Makes Stock More Accessible with a Stock Split
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.